Key result
Highest cardiometabolic risk score linked to ~16% higher all-cause mortality vs. lowest quartile.
Why the study?
Does a higher cardiometabolic risk factors cluster score increase all-cause mortality in patients with type 2 diabetes?
Cohort (n=10,310)
Does a higher cardiometabolic risk factors cluster score increase all-cause mortality in patients with type 2 diabetes?
Answers are grounded in this paper and cite their sources.
A clustered cardiometabolic risk factor score is significantly associated with increased all-cause mortality in patients with type 2 diabetes, highlighting the need for comprehensive risk management.
OBJECTIVE: To investigate the association between the cardiometabolic risk factors cluster (CRFC) and all-cause mortality in type 2 diabetes (T2D). METHODS: Data from the Zhejiang Rural T2D Cohort (2016-2024) included 10,310 participants. Four cardiometabolic risk factors (CRFs) were evaluated: central obesity, elevated blood pressure, high triglycerides (TG), and low high-density lipoprotein cholesterol (HDL-C). After adjusting for confounders, multivariate Cox regression models were constructed to estimate hazard ratios (HRs). A Total CRFs Score (TCRFS), weighted by regression coefficients of individual CRFs, was stratified into four groups based on quartiles (<P25, P25-P50, P50-P75, and ≥P75). The TCRFS and TCRFS-based groupings were analyzed for associations with all-cause mortality, including age- and sex-stratified analyses. RESULTS: Participants had a mean age of 63.54 ± 9.77 years, with the most prevalent CRFs being elevated blood pressure (86.97%), followed by elevated TG (41.21%), low HDL-C (38.71%), and central obesity (32.96%). Over a mean 8.12 ± 1.71 years of follow-up, 1,770 deaths occurred (death density: 211.21/10,000 person-years). No single CRF, except for TG, showed a significant association with all-cause mortality, whereas the TCRFS was a significant predictor (HR = 2.719, 95%CI (1.360, 5.437), p = 0.005). Furthermore, participants in the highest TCRFS quartile (≥P75) had a significantly higher mortality risk compared to those in the lowest quartile (<P25) (HR = 1.155, 95% CI: 1.030-1.294, P = 0.013). CONCLUSION: CRFC is significantly associated with increased all-cause mortality risk in T2D patients. Early comprehensive assessment and intervention for cardiometabolic risk factors may reduce mortality in this population.
No takes yet. Share an insight, caveat, or question.
He et al. (2026) conducted a cohort in Type 2 diabetes (n=10,310). Cardiometabolic risk factors cluster (highest TCRFS quartile) vs. Lowest TCRFS quartile (<P25) was evaluated on All-cause mortality (HR 1.155, 95% CI 1.030-1.294, p=0.013). The highest quartile of the Total Cardiometabolic Risk Factors Score was associated with increased all-cause mortality compared to the lowest quartile (HR 1.155; 95% CI 1.030-1.294; P=0.013).
Synapse has enriched 10 related papers. Consider them for comparative context: